Loading...
Home2020-09-02T22:15:22+00:00

Announcements

A Unique Collaboration

This unique collaborative team brings together all the capabilities needed to address the COVID-19 pandemic – computational expertise, clinical experience, advanced laboratory proficiency, and a deep knowledge of human and coronavirus genetics.

COV-IRT Project Goals:

  • Enhance public datasets to reveal host infection dynamics for SARS-CoV-2 to improve medical treatment options for COVID-19 patients.

  • Determine and design optimal targets for therapeutics against SARS-CoV-2

  • Creating new drug delivery systems based on targets

  • Test newly developed therapeutics in both in vitro and in vivo SARS-CoV-2 models

  • Apply for human clinical trials

LEARN MORE
COV-IRT Symbol

Team Members

COV-IRT was founded by Dr. Afshin Beheshti, Dr. Todd Treangen, and Dr. Krista Ternus and is led by Drs. Beheshti and Treangen. Members include scientists and experts from across the world, directors from both academic institutions and hospitals, senior and junior faculty, leaders from industry, graduate students, and postdocs.

Dr. Afshin Beheshti

Dr. Afshin Beheshti

Principal Investigator and Bioinformatician at NASA Ames Research Center/KBR, Adjunct Assistant Professor at Rutgers, and Visiting Researcher at Broad Institute

Dr. Todd Treangen

Dr. Todd Treangen

Assistant Professor in the Department of Computer Science, Rice University

Dr. Krista Ternus

Dr. Krista Ternus

Genomics Specialist in Biological Sciences, Signature Science, LLC

See All Team Members

The Latest from the Newsroom

The COVID-19 International Research Team is already producing interesting analyses that can potentially bring mechanistic understanding of SARS-CoV-2 and help identify therapies. Visit the Newsroom for media coverage, research updates, upcoming events, and resources.

Visit the Newsroom